A randomised trial of early ultrasound screening for fetal abnormality
| ISRCTN | ISRCTN37543746 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN37543746 |
| Protocol serial number | RRCC138R R6003 |
| Sponsor | NHS R&D Regional Programme Register - Department of Health (UK) |
| Funder | NHS Executive Northern and Yorkshire (UK) |
- Submission date
- 23/01/2004
- Registration date
- 23/01/2004
- Last edited
- 09/03/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Royal Victoria Infirmary
Dept of Obstetrics & Gynaecology 4th Floor
Leazes Wing
Queen Victoria Road
Newcastle upon Tyne
NE1 4LP
United Kingdom
| Phone | +44 (0)191 282 4132 |
|---|---|
| s.c.robson@ncl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A randomised trial of early ultrasound screening for fetal abnormality |
| Study objectives | This is a randomised trial to evaluate the effects on pregnancy management and outcome of adding early ultrasound screening for structural and chromosomal abnormalities to an existing antenatal screening programme (maternal serum screening at 16 weeks and ultrasound screening at 18-20 weeks). The general hypothesis is that early ultrasound screening will improve maternal psychological outcome following termination of pregnancy (TOP) for fetal abnormality. The specific hypotheses to be tested are; Primary Addition of early ultrasound screening reduces grief, depression and distress after TOP for fetal abnormality. Secondary Addition of early ultrasound screening 1. Does not increase maternal anxiety in those receiving false positive results, while in those receiving screen negative results it 2. Provides reassurance 3. Has beneficial effects on attitudes to the fetus and 4. Has beneficial effects on smoking. The cost-effectiveness of introducing early ultrasound screening will also be examined. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Pregnancy and childbirth: Pregnancy |
| Intervention | 1. Early ultrasound screening for structural and chromosomal abnormalities 2. Standard care |
| Intervention type | Other |
| Primary outcome measure(s) |
1. In women undergoing TOP |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 10/01/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Female |
| Target sample size at registration | 15000 |
| Key inclusion criteria | 15000 women (7500 in each arm) - estimate ~50 women undergoing TOP in each arm. 225 women with false positive results and 225 screen negative women. |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 10/01/2000 |
| Date of final enrolment | 10/01/2003 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
NE1 4LP
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
09/03/2018: No publications found, verifying study status with principal investigator.
29/02/2016: No publications found, verifying study status with principal investigator.